Media Summary: REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone. New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a ... New insights into the SUMMIT trial, investigating tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) ...

Aha 24 Late Breaking Discussion - Detailed Analysis & Overview

REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone. New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a ... New insights into the SUMMIT trial, investigating tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) ... Semaglutide shows increased benefits in CKD patients based on their cardiovascular status and risk profile. Dr Harriette Van ... Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS ... Clyde Yancy, MD, Mariell Jessup MD, and Neil Stone MD

... at Heart Association I think there will be four GALACTIC-HF. TIPS. SAMSON. RIVER. One Month DAPT. And More! Listen to Dr. Donald Lloyd-Jones and Dr. Manesh Patel, ... Program Chair Frank Sellke, MD provides a preview of select

Photo Gallery

AHA 24 Late-Breaking Discussion: REALIZE-K
AHA 24 Late-Breaking Discussion: The NUDGE-FLU Study
AHA 24 Late-Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity
AHA 24 Late-Breaking Discussion: FLOW: Benefits of Semaglutide on CKD by CV Status or Risk
AHA 24 Late-Breaking Discussion: The ZODIAC Trial
Overview of Late Breaking Clinical Trials HD
AHA 25 Late-breaking Discussion: The BETTER-BP Trial
Scientific Sessions 2014—Big, Late-breaking Science
Preview of Late-Breaking Research at AHA18 in Chicago
AHA 25 Late-breaking Discussion: Comparison from the TUXEDO-2 Trial
#AHA20 Late-Breaking Science Preview
Preview: Late Breaking Clinical Trials
View Detailed Profile
AHA 24 Late-Breaking Discussion: REALIZE-K

AHA 24 Late-Breaking Discussion: REALIZE-K

REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.

AHA 24 Late-Breaking Discussion: The NUDGE-FLU Study

AHA 24 Late-Breaking Discussion: The NUDGE-FLU Study

New insights from the NUDGE-FLU Program on electronic nudges to increase influenza vaccination amongst patients with a ...

AHA 24 Late-Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity

AHA 24 Late-Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity

New insights into the SUMMIT trial, investigating tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) ...

AHA 24 Late-Breaking Discussion: FLOW: Benefits of Semaglutide on CKD by CV Status or Risk

AHA 24 Late-Breaking Discussion: FLOW: Benefits of Semaglutide on CKD by CV Status or Risk

Semaglutide shows increased benefits in CKD patients based on their cardiovascular status and risk profile. Dr Harriette Van ...

AHA 24 Late-Breaking Discussion: The ZODIAC Trial

AHA 24 Late-Breaking Discussion: The ZODIAC Trial

Key findings from the ZODIAC trial investigating the role of a decision support system in optimising lipid-lowering therapy for ACS ...

Overview of Late Breaking Clinical Trials HD

Overview of Late Breaking Clinical Trials HD

Clyde Yancy, MD, Mariell Jessup MD, and Neil Stone MD

AHA 25 Late-breaking Discussion: The BETTER-BP Trial

AHA 25 Late-breaking Discussion: The BETTER-BP Trial

AHA

Scientific Sessions 2014—Big, Late-breaking Science

Scientific Sessions 2014—Big, Late-breaking Science

Elliott Antman, MD, President of the

Preview of Late-Breaking Research at AHA18 in Chicago

Preview of Late-Breaking Research at AHA18 in Chicago

... at Heart Association I think there will be four

AHA 25 Late-breaking Discussion: Comparison from the TUXEDO-2 Trial

AHA 25 Late-breaking Discussion: Comparison from the TUXEDO-2 Trial

AHA

#AHA20 Late-Breaking Science Preview

#AHA20 Late-Breaking Science Preview

GALACTIC-HF. TIPS. SAMSON. RIVER. One Month DAPT. And More! Listen to Dr. Donald Lloyd-Jones and Dr. Manesh Patel, ...

Preview: Late Breaking Clinical Trials

Preview: Late Breaking Clinical Trials

Program Chair Frank Sellke, MD provides a preview of select

AHA Scientific Sessions 2018 with Clyde Yancy, MD and Robert Bonow, MD  Ep 2

AHA Scientific Sessions 2018 with Clyde Yancy, MD and Robert Bonow, MD Ep 2

Former